Kohjin Bio Co., Ltd. (177A) Stock Forecast & Analysis

Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Kohjin Bio Co., Ltd. (177A:JPX), powered by AI.

Current Price
¥1,019
P/E Ratio
6.2
Market Cap
5.0B
Sector
Healthcare
What is the Kohjin Bio Co., Ltd. stock price forecast?

Kohjin Bio Co., Ltd. is currently trading at ¥1,019. View real-time AI analysis on Alpha Lenz.

What is Kohjin Bio Co., Ltd. insider trading activity?

View the latest insider trading data for Kohjin Bio Co., Ltd. on Alpha Lenz.

What is Kohjin Bio Co., Ltd.'s P/E ratio?

Kohjin Bio Co., Ltd.'s P/E ratio is 6.2.

Kohjin Bio Co., Ltd.

JPX · 177A
¥1,019+35(+3.56%)Market closedJPX regular session 09:00–15:00 JST
Ask about Kohjin Bio Co., Ltd.'s future dividend policy...
Alpha Chat Insight

Kohjin Bio Co., Ltd. trades at a P/E of 6.2 (undervalued) with strong ROE of 17.4%.

Ask for details

Company Overview

Kohjin Bio Co., Ltd. operates as a company focused on the development, manufacturing, and distribution of biological and biochemical products. With its roots in innovation and scientific advancement, Kohjin Bio is renowned for producing high-quality nutritional supplements and health-related solutions. The company's primary function is to cater to the wellness and healthcare industry, offering products that support and enhance health through scientifically backed formulations. Notable features of Kohjin Bio's offerings include an emphasis on naturally derived ingredients and cutting-edge biotechnological processes. These products are critical to medical and health sectors, impacting areas such as dietary supplementation and preventive healthcare. As a significant player in the life sciences market, Kohjin Bio Co., Ltd. contributes to the well-being of populations by delivering trusted and effective health products, standing as a reputable entity in both domestic and international markets. Its role is crucial in driving innovations that meet the growing demand for health-conscious living solutions.

SectorHealthcare
IndustryBiotechnology
Employees167

Company Statistics

FY 2025

Profile

¥4,963,306,824Market Cap
¥5,206,287,000Revenue
0.00Shares Out
167Employees

Margins

45.45%Gross
27.97%EBITDA
19.04%Operating
19.50%Pre-Tax
15.27%Net

Valuation

6.25P/E
0.86P/B
0.95EV/Sales
2.88EV/EBITDA
176.91P/FCF

Growth (CAGR)

9.67%Rev 3Yr
N/ARev 5Yr
0.74%Op Inc 3Yr
N/AOp Inc 5Yr
10.59%Net Inc 3Yr
N/ANet Inc 5Yr

Returns

10.15%ROA
17.42%ROE
13.35%ROIC

Financial Health

¥3,149,267,000Cash & Cash Equivalents
¥135,561,000Net Debt
56.81%Debt/Equity
N/AInterest Cov

Frequently Asked Questions

Kohjin Bio Co., Ltd. (ticker: 177A) is a company listed on JPX in the Healthcare sector (Biotechnology). It has approximately 167 employees. Market cap is $5.0B.

The current price is 1,019 with a P/E ratio of 6.25x and P/B of 0.86x.

ROE is 17.42% and operating margin is 19.04%. Annual revenue is $5.2B.

Alpha Lenz
Singapore
Treasurer Pte Ltd | License: 202346277E
9 Straits View Marina One West Tower #05-07 Singapore 018937
contact@treasurer.co.kr
©2026 Treasurer Pte Ltd. All rights reserved.
Kohjin Bio Co., Ltd. (177A) Stock Forecast 2026 ¥1,019 — Price, Financials & Analyst Targets | Alpha Lenz